← FDA Drug Approvals (Drugs@FDA)

NEVIRAPINE

NDA · New Drug Application · Sponsor: CIPLA LIMITED · Approved 2012-04-30

Drug application

FDA Application #

NDA202212

Application type

New Drug Application

Brand name

NEVIRAPINE

Generic name

Nevirapine

Active ingredients

NEVIRAPINE

Dosage form

TABLET, FOR SUSPENSION

Route

ORAL

Marketing status

None (Tentative Approval)

Sponsor

CIPLA LIMITED

First approval

2012-04-30

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown